111 results
8-K
CHRS
Coherus Biosciences Inc
9 May 24
Entry into a Material Definitive Agreement
7:30am
of this nature.
The foregoing description of the material terms of the Revenue Purchase and Sale Agreement is qualified in its entirety by the full
8-K
t9mcb
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-2.1
v8gb z2urm
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
fozme1au4wj 5g753
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B3
r1p70ykx0ykpy9 3k
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
xxoa554jo2dyk9s3
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
nqkab 8865dm
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
k50p ej5u2lt
16 Jun 23
Business combination disclosure
5:17pm
425
4pio16 9y2
16 Jun 23
Business combination disclosure
5:16pm